Thomas A. Lanz
Impact in
- Biological Psychiatry top 2%
- Tryptophan and brain disorders
- Physiology top 2%
- Alzheimer's disease research and treatments
Papers in
-
- Neuroscience and Neuropharmacology Research 6
- Co-authors
- Kalpana Merchant (5 shared papers)Robin J. Kleiman (6 shared papers)Veronica Reinhart (7 shared papers)Susan E. Bove (5 shared papers)Dmitri Volfson (3 shared papers)Joel B. Schachter (4 shared papers)David A. Lewis (3 shared papers)Wade J. Adams (1 shared paper)
- Journals
- Journal of Pharmacology and Experimental Therapeutics (6 papers)Molecular Therapy — Methods & Clinical Development (3 papers)Alzheimer s & Dementia (3 papers)Physiology & Behavior (2 papers)PLoS ONE (2 papers)
- Partner nations
- United StatesUnited KingdomSwitzerland
In The Last Decade
Thomas A. Lanz
40 papers receiving 2.2k citations
Thomas A. Lanz's Hit Papers
Peers
Comparison fields: 5 of 115
- Biological Psychiatry 178
- Physiology 781
- Neurology 245
- Developmental Neuroscience 110
- Cellular and Molecular Neuroscience 478
Countries citing papers authored by Thomas A. Lanz
This map shows the geographic impact of Thomas A. Lanz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas A. Lanz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas A. Lanz more than expected).
Fields of papers citing papers by Thomas A. Lanz
This network shows the impact of papers produced by Thomas A. Lanz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas A. Lanz. The network helps show where Thomas A. Lanz may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas A. Lanz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | LRRK2 activation in idiopathic Parkinson’s disease Hit paper breakdown → | 2018 | 391 |
| 2 | 2012 | 258 | |
| 3 | 2003 | 192 | |
| 4 | 2019 | 138 | |
| 5 | 2015 | 119 | |
| 6 | 2003 | 118 | |
| 7 | 2004 | 113 | |
| 8 | 2006 | 107 | |
| 9 | 2011 | 79 | |
| 10 | 2010 | 73 | |
| 11 | 2004 | 53 | |
| 12 | 1999 | 49 | |
| 13 | 2015 | 43 | |
| 14 | 2013 | 43 | |
| 15 | 2015 | 43 | |
| 16 | 2010 | 40 | |
| 17 | 2006 | 37 | |
| 18 | 2018 | 37 | |
| 19 | 2017 | 34 | |
| 20 | 2007 | 30 |
About Thomas A. Lanz
Thomas A. Lanz is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience, Oncology, Physiology and Genetics, having authored 44 papers that have together received 2.2k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (10 papers), Neuroscience and Neuropharmacology Research (6 papers), Virus-based gene therapy research (6 papers), Drug Transport and Resistance Mechanisms (6 papers), CAR-T cell therapy research (4 papers), Neurogenesis and neuroplasticity mechanisms (3 papers), Cholinesterase and Neurodegenerative Diseases (3 papers) and Computational Drug Discovery Methods (3 papers). The work is most often cited by research in Biological Psychiatry (178 citations), Physiology (781 citations), Neurology (245 citations), Developmental Neuroscience (110 citations) and Cellular and Molecular Neuroscience (478 citations). Thomas A. Lanz has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Kalpana Merchant, Robin J. Kleiman, Veronica Reinhart, Susan E. Bove, Dmitri Volfson, Joel B. Schachter, David A. Lewis, Wade J. Adams, Teresa G. Hastings and Laurie H. Sanders. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, Molecular Therapy — Methods & Clinical Development, Alzheimer s & Dementia, Physiology & Behavior and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.